Watch Ticker

Alcon Inc. Ordinary Shares

Go to Alcon Inc. Ordinary Shares Website

$87.82

-0.05 (-0.06%)

Live

Previous Close

$87.87

Day Range

$86.12 - $87.96

Previous Day Range

$86.2 - $87.92

Market Cap

$43.5 billion USD

Day Vol.

1.9 million

Previous Day Vol.

945212

Currency

USD

Primary Exchange

New York Stock Exchange

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact len...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Vandana Singh - Alcon Secures First FDA Approval Since Novartis Spin-Off In 2019

Alcon's Tryptyr (acoltremon ophthalmic solution) 0.003% has been approved by the FDA for the treatment of dry eye disease. The approval is supported by positive results from two Phase 3 clinical trials.

Related tickers: ALC, LADX.

Read Full Article

Globe Newswire - Gordon Schanzlin New Vision Institute First in Region to Offer Groundbreaking Alcon Sitemap Technology for Personalized Vision Correction

Gordon Schanzlin New Vision Institute (GSNVI) will be the first in the region to offer Alcon's revolutionary Sitemap diagnostic platform, a personalized refractive surgery technology. This will give GSNVI patients an exclusive opportunity to experience a new era in vision correction.

Related tickers: ALC.

Read Full Article

Trending Tickers

Please sign in to view